FGFR1 and neoplasm: For instance, in SCLC, FGFR1 oncogenic activation reveals an alternative cell of origin and influences tumor phenotype, promoting low-grade NE lesions in specific contexts while impairing the development of typical SCLC.85 These findings highlight the nuanced roles of FGFR signaling in determining tumor lineage and phenotype.